New Drug Information: Bortezomib

Also known as: Velcade

Drug Information: Bortezomib is a proteasome inhibitor, a type of drug which targets structures inside the cell responsible for breaking down proteins. It has been theorized that cancerous cells are particularly vulnerable to this sort of induced dysfunction. It is typically given twice-weekly; weekly regimens were attempted in trials, and had fewer side effects but limited response rates.